A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06625242
- Locations
- 🇰🇷
Eisai site #11, Anyang-si, Korea, Republic of
🇰🇷Eisai site #01, Busan, Korea, Republic of
🇰🇷Eisai site #09, Daegu, Korea, Republic of
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 2040
- Registration Number
- NCT06246123
- Locations
- 🇰🇷
Site #28, Ansan, Korea, Republic of
🇰🇷Site #36, Daegu, Korea, Republic of
🇰🇷Site #35, Gyeonggi, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
- First Posted Date
- 2022-09-09
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT05533814
- Locations
- 🇰🇷
Eisai Site #3, Daejeon, Korea, Republic of
🇰🇷Eisai Site #10, Jeonju, Korea, Republic of
🇰🇷Eisai Site #5, Seoul, Korea, Republic of
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
- Conditions
- Interventions
- First Posted Date
- 2022-05-16
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT05375136
- Locations
- 🇰🇷
Eisai Site #14, Seoul, Korea, Republic of
🇰🇷Eisai Site #04, Bundang, Korea, Republic of
🇰🇷Eisai Site #02, Busan, Korea, Republic of
A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 172
- Registration Number
- NCT05366036
- Locations
- 🇰🇷
Site #12, Seoul, Korea, Republic of
🇰🇷Site #03, Kwangju, Korea, Republic of
🇰🇷Site #01, Daegu, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 201
- Registration Number
- NCT05312632
- Locations
- 🇰🇷
Eisai Site #11, Busan, Korea, Republic of
🇰🇷Eisai Site #3, Busan, Korea, Republic of
🇰🇷Eisai Site #16, Daegu, Korea, Republic of
A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 658
- Registration Number
- NCT05225207
- Locations
- 🇰🇷
Site #03, Seongnam, Gyeonggi-do, Korea, Republic of
🇰🇷Site #32, Cheonan, Chungcheongnam-do, Korea, Republic of
🇰🇷Site #38, Bucheon, Gyeonggi-do, Korea, Republic of
A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT05225324
- Locations
- 🇰🇷
Site #03, Cheongju, Chungcheongbuk-do, Korea, Republic of
🇰🇷Site #11, Ilsan, Gyeonggi-do, Korea, Republic of
🇰🇷Site #23, Wonju-si, Gangwon-do, Korea, Republic of
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 676
- Registration Number
- NCT05208268
- Locations
- 🇰🇷
Site #19, Cheongju, Chungcheongbuk-do, Korea, Republic of
🇰🇷Site #01, Chungju, Chungcheongbuk-do, Korea, Republic of
🇰🇷Site #31, Bucheon, Gyeongji-do, Korea, Republic of
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting
- First Posted Date
- 2018-02-28
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Eisai Korea Inc.
- Target Recruit Count
- 201
- Registration Number
- NCT03448445
- Locations
- 🇰🇷
Eisai Trial site_07, Guri, Korea, Republic of
🇰🇷Eisai Trial site_06, Seoul, Korea, Republic of
🇰🇷Eisai Trial site_04, Seoul, Korea, Republic of